Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rifampicin for the treatment of a cardiogenic shock related to mavacamten toxicity: the worse and the best of drug interactions from a case report.

European heart journal. Case reports·2026
Same author

Temporal trends in characteristics, management and prognosis of patients with acute heart failure through two repeated snapshots.

Heart (British Cardiac Society)·2026
Same author

Factors associated with variations in the 6-minute walk distance during the follow-up of patients with systemic sclerosis.

Arthritis research & therapy·2026
Same author

Heart failure hospitalization reduction and long-term safety with remote pulmonary artery pressure monitoring: results of the CardioMEMS heart failure system outside United States (of America) post-market study.

European heart journal open·2026
Same author

Laminopathies: natural history and risk prediction of heart failure.

European heart journal·2026
Same author

Novel association of <i>NAV3</i> with dilated cardiomyopathy and its role in cardiac fibrosis.

American journal of physiology. Heart and circulatory physiology·2026

Related Experiment Video

Updated: Jun 7, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

[Acute events in heart failure].

Pascal de Groote1

  • 1Service de cardiologie C, pôle de cardiologie et maladies vasculaires, Hôpital cardiologique, CHRU, 59037 Lille Cedex, France. pdegroote@chru-lille.fr

La Revue Du Praticien
|November 2, 2010
PubMed
Summary

Patients with chronic heart failure face risks of acute decompensation, arrhythmias, and sudden cardiac death. Regular monitoring and timely management are crucial for preventing severe complications and improving outcomes in heart failure patients.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Critical Care Medicine

Context:

  • Chronic heart failure (CHF) patients are susceptible to acute decompensation.
  • Acute events include heart failure exacerbation, arrhythmias, and conduction disturbances.
  • Sudden cardiac death is a severe complication, often linked to ventricular tachycardia.

Purpose:

  • To highlight the major acute complications in chronic heart failure patients.
  • To emphasize the importance of identifying causes for worsening heart failure.
  • To stress the necessity of regular monitoring and therapeutic management.

Summary:

  • Acute pulmonary edema, though manageable with nitrates, signifies worsening heart failure.
  • Biological complications like renal failure and electrolyte imbalances (hypo- or hyperkalemia) can occur.

Related Experiment Videos

Last Updated: Jun 7, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

  • Preventive strategies involve consistent clinical and biological monitoring and prompt therapeutic intervention.

    • Impact:

    • Proactive management can mitigate risks of acute decompensation and sudden cardiac death.
    • Early detection and treatment of complications improve patient prognosis.
    • This approach underscores the importance of vigilant care in managing chronic heart failure.